126 related articles for article (PubMed ID: 32988909)
1. Is it Necessary to Confirm Negative Margins in Gastrectomy for Peritoneal Lavage Cytology-positive Gastric Cancer?
Endo S; Fujiwara Y; Yamatsuji T; Nishikawa K; Fujitani K; Ikenaga M; Kawada J; Okamoto Y; Kubota H; Higashida M; Ueno T
Anticancer Res; 2020 Oct; 40(10):5807-5813. PubMed ID: 32988909
[TBL] [Abstract][Full Text] [Related]
2. Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy.
Yasufuku I; Nunobe S; Ida S; Kumagai K; Ohashi M; Hiki N; Sano T
Gastric Cancer; 2020 Mar; 23(2):319-327. PubMed ID: 31350702
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for cytology-positive gastric cancer.
Endo S; Ikenaga M; Ohta K; Ueda M; Tsuda Y; Kato R; Itakura H; Matsuyama J; Nishikawa K; Yamada T
Surg Today; 2019 Jan; 49(1):56-64. PubMed ID: 30167924
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of gastrectomy for gastric cancer patients with positive lavage cytology without gross peritoneal dissemination.
Kobayashi H; Honda M; Kawamura H; Takiguchi K; Muto A; Yamazaki S; Teranishi Y; Shiraso S; Kono K; Hori S; Kamiga T; Iwao T; Yamashita N
J Surg Oncol; 2022 Mar; 125(4):615-620. PubMed ID: 34985764
[TBL] [Abstract][Full Text] [Related]
5. The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
Kano K; Aoyama T; Maezawa Y; Nakajima T; Ikeda K; Yamada T; Sato T; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
Int J Clin Oncol; 2017 Oct; 22(5):887-896. PubMed ID: 28456896
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Postoperative Chemotherapy After Resection that Leaves No Macroscopically Visible Disease of Gastric Cancer with Positive Peritoneal Lavage Cytology (CY1) or Localized Peritoneum Metastasis (P1a): A Multicenter Retrospective Study.
Yamaguchi T; Takashima A; Nagashima K; Makuuchi R; Aizawa M; Ohashi M; Tashiro K; Yamada T; Kinoshita T; Hata H; Kawachi Y; Kawabata R; Tsuji T; Hihara J; Sakamoto T; Fukagawa T; Katai H; Higuchi K; Boku N
Ann Surg Oncol; 2020 Jan; 27(1):284-292. PubMed ID: 31535301
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
[TBL] [Abstract][Full Text] [Related]
8. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
9. The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.
Masuda T; Kuramoto M; Shimada S; Ikeshima S; Yamamoto K; Nakamura K; Yoshimatsu S; Urata M; Baba H
Int J Clin Oncol; 2016 Apr; 21(2):289-294. PubMed ID: 26296529
[TBL] [Abstract][Full Text] [Related]
10. Observational Study of Peritoneal Washing Cytology-Positive Gastric Cancer without Gross Peritoneal Metastasis in Patients who Underwent Radical D2 Gastrectomy.
Shim HJ; Kim HJ; Lee SH; Bae WK; Hwang EC; Cho SH; Chung IJ; Bang HJ; Hwang JE
Sci Rep; 2020 Jun; 10(1):9549. PubMed ID: 32533084
[TBL] [Abstract][Full Text] [Related]
11. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology (CY1) or localized peritoneal metastasis (P1a): a multi-institutional retrospective study.
Yamaguchi T; Takashima A; Nagashima K; Terashima M; Aizawa M; Ohashi M; Tanaka R; Yamada T; Kinoshita T; Matsushita H; Ishiyama K; Hosoda K; Yuasa Y; Haruta S; Kakihara N; Nishikawa K; Yunome G; Satoh T; Fukagawa T; Katai H; Boku N
Gastric Cancer; 2021 May; 24(3):701-709. PubMed ID: 33179192
[TBL] [Abstract][Full Text] [Related]
12. Influence of positive margins on tumour recurrence and overall survival after gastrectomy for gastric cancer.
Juez LD; Barranquero AG; Priego P; Cuadrado M; Blázquez L; Sánchez-Picot S; Fernández-Cebrián JM; Galindo J
ANZ J Surg; 2021 Jul; 91(7-8):E465-E473. PubMed ID: 34013576
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of initial treatment for peritoneal lavage cytology-positive gastric cancer: outcomes according to treatment strategy.
Yago A; Haruta S; Ueno M; Ogawa Y; Shimoyama H; Ohkura Y; Udagawa H
World J Surg Oncol; 2022 Feb; 20(1):35. PubMed ID: 35168610
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of peritoneal lavage cytology at three cavities in patients with gastric cancer.
Kano Y; Kosugi S; Ishikawa T; Otani T; Muneoka Y; Sato Y; Hanyu T; Hirashima K; Bamba T; Wakai T
Surgery; 2015 Dec; 158(6):1581-9. PubMed ID: 25958064
[TBL] [Abstract][Full Text] [Related]
15. Impact of positive microscopic resection margins (R1) after gastrectomy in diffuse-type gastric cancer.
Gaspar-Figueiredo S; Allemann P; Borgstein ABJ; Joliat GR; Luzuy-Guarnero V; Brunel C; Sempoux C; Gisbertz SS; Demartines N; van Berge Henegouwen MI; Schäfer M; Mantziari S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11105-11115. PubMed ID: 37344606
[TBL] [Abstract][Full Text] [Related]
16. When is curative gastrectomy justified for gastric cancer with positive peritoneal lavage cytology but negative macroscopic peritoneal implant?
Miyashiro I; Takachi K; Doki Y; Ishikawa O; Ohigashi H; Murata K; Sasaki Y; Imaoka S; Nakaizumi A; Takenaka A; Furukawa H; Hiratsuka M
World J Surg; 2005 Sep; 29(9):1131-4. PubMed ID: 16086213
[TBL] [Abstract][Full Text] [Related]
17. Is D2 Lymphadenectomy Essential for Cytology-positive Gastric Cancer? A Retrospective Analysis.
Endo S; Nishikawa K; Fujitani K; Matsuyama J; Ikenaga M; Yamada T; Tamura S; Sasaki YO
Anticancer Res; 2019 Nov; 39(11):6209-6216. PubMed ID: 31704849
[TBL] [Abstract][Full Text] [Related]
18. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
[TBL] [Abstract][Full Text] [Related]
19. Pathological features and survival analysis of gastric cancer patients with positive surgical margins: A large multicenter cohort study.
Tu RH; Lin JX; Wang W; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Zhou ZW; Huang CM
Eur J Surg Oncol; 2019 Dec; 45(12):2457-2464. PubMed ID: 31362841
[TBL] [Abstract][Full Text] [Related]
20. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
